Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapy
J Am Acad Dermatol
.
2021 Jul;85(1):e39-e40.
doi: 10.1016/j.jaad.2021.03.006.
Epub 2021 Mar 4.
Authors
Robert Bissonnette
1
,
Linda Stein Gold
2
,
David S Rubenstein
3
,
Anna M Tallman
4
,
April W Armstrong
5
Affiliations
1
Innovaderm Research Inc, Montréal, Québec, Canada. Electronic address: rbissonnette@innovaderm.com.
2
Henry Ford Health System, Detroit, Michigan.
3
Dermavant Sciences, Inc, Durham, North Carolina.
4
Dermavant Sciences Inc, Long Beach, California.
5
Keck School of Medicine of the University of Southern California, Los Angeles, California.
PMID:
33676999
DOI:
10.1016/j.jaad.2021.03.006
No abstract available
Publication types
Letter
Comment
MeSH terms
Folliculitis* / diagnosis
Humans
Resorcinols
Stilbenes*
Substances
Resorcinols
Stilbenes
tapinarof